Inogen | INGN - Current Liabilities


Inogen reported $64.94M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Accuray USD 199.44M 4.83M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 106.93M 14.23M Jun/2026
AtriCure USD 81.92M 8.72M Jun/2026
Baxter International USD 3.59B 102M Jun/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Boston Scientific USD 6.43B 1.86B Jun/2026
Cooper Companies USD 1.8B 209M Mar/2026
Dexcom USD 2.36B 133.9M Jun/2026
Edwards Lifesciences USD 1.51B 98.9M Jun/2026
Globus Medical USD 479.35M 3.12M Jun/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 744.2M 56.7M Jun/2026
Medtronic USD 9.5B 440M Dec/2025
Orthofix International USD 157.01M 4.02M Jun/2026
Philips EUR 7.42B 8M Jun/2026
ResMed USD 1.4B 43.9M Jun/2026
Steris USD 1.28B 138.3M Jun/2026
Stryker USD 6.68B 369M Jun/2026
Tandem Diabetes Care USD 253M 5.05M Jun/2026
Teleflex USD 720.38M 7.67M Jun/2026
X T L Biopharmaceuticals USD 420K 341K Dec/2025
Zimmer Biomet Holdings USD 3.01B 149.2M Jun/2026